+499.5%
MRNA vs ADVB
+5.8%
+493.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ADVB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.7% | -1.5% | -2.2% |
| 7D | +5.5% | -3.8% | +9.2% | +5.4% |
| 30D | +158.7% | +17.6% | +141.2% | +158.7% |
| 3M | +182.1% | +119.1% | +63.0% | +168.0% |
| 6M | +151.8% | +103.4% | +48.4% | +130.7% |
| YTD | +393.6% | +59.8% | +333.7% | +360.6% |
| 1Y | +499.5% | +8.5% | +490.9% | +503.4% |
| All | +499.5% | +5.8% | +493.6% | +503.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ADVB.
Daily Out/Under-Performance
Portfolio return minus ADVB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ADVB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ADVB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling